2 days ago
DNTH
AnalystsDanielle BrillDanielle Brill's Stock Forecasts
AnalystsDanielle Brill
Analyst Ranking
Top 9%
#457 out of 5346 analysts
Average Return
+18.88%
Win Rate
52%59 out of 113
Risk vs Reward
Poor
Good
Danielle Brill's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +1,074.35% | $5.42 | $63.65 | 2024-10-10 - 2025-10-09 | Buy |
Palvella Therapeutics IncPVLA | +300.48% | $31.00 | $124.15 | 2025-07-21 - 2026-07-20 | Strong Buy |
Dianthus Therapeutics IncDNTH | +206.43% | $35.55 | $108.92 | 2025-10-14 - 2026-08-07 | Strong Buy |
Dianthus Therapeutics IncDNTH | +185.73% | $38.12 | $108.92 | 2026-01-08 - 2026-08-07 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +152.18% | $16.06 | $40.50 | 2025-07-21 - 2026-06-26 | Strong Buy |
Danielle Brill Analyst Color
Get additional color on Danielle Brill's coverage of popular stocks
a month ago
NBIX
3 months ago
RAPP
3 months ago
PRAX
3 months ago
NBIX
3 months ago
BBIO
5 months ago
DNTH
5 months ago
BBIO
6 months ago
NBIX
6 months ago
CNTA
7 months ago
ARGX
7 months ago
NBIX
7 months ago
DNTH
7 months ago
CNTA
7 months ago
BBIO
8 months ago
PVLA
9 months ago
IRON
9 months ago
BBIO
10 months ago
ALNY
10 months ago
PVLA
2 years ago
SRPT
Danielle Brill's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Climb Bio IncCLYM | 2 | Strong Buy | $25.00 | +78.57% | Maintains | a day ago |
Dianthus Therapeutics IncDNTH | 4 | Strong Buy | $128.00 | +17.52% | Maintains | 2 days ago |
Harmony Biosciences Holdings IncHRMY | 11 | Hold | $34.00 | -11.48% | Maintains | 3 days ago |
Vertex Pharmaceuticals IncVRTX | 3 | Strong Buy | $565.00 | +13.90% | Maintains | 3 days ago |
Alnylam Pharmaceuticals IncALNY | 6 | Strong Buy | $315.00 | +43.70% | Maintains | 4 days ago |
Neurocrine Biosciences IncNBIX | 12 | Strong Buy | $213.00 | +30.35% | Maintains | 5 days ago |
Biogen IncBIIB | 2 | Strong Buy | $235.00 | +13.01% | Upgrades | a month ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $616.00 | +70.75% | Maintains | 2 months ago |
Apogee Therapeutics IncAPGE | 2 | Hold | $81.00 | -39.93% | Maintains | 2 months ago |
Immunovant IncIMVT | 7 | Hold | $30.00 | -24.91% | Maintains | 3 months ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $56.00 | +23.10% | Assumes | 3 months ago |
Insmed IncINSM | 1 | Strong Buy | $185.00 | +41.11% | Maintains | 3 months ago |
Wave Life Sciences LtdWVE | 1 | Strong Buy | $15.00 | +145.90% | Maintains | 3 months ago |
Bridgebio Pharma IncBBIO | 5 | Strong Buy | $102.00 | +20.74% | Maintains | 3 months ago |
Maze Therapeutics IncMAZE | 2 | Strong Buy | $64.00 | +123.39% | Maintains | 4 months ago |
Disc Medicine IncIRON | 7 | Strong Buy | $83.00 | +7.18% | Maintains | 5 months ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Strong Buy | $38.00 | -6.17% | Maintains | 6 months ago |
Argenx SeARGX | 8 | Strong Buy | $1,030.00 | +19.07% | Maintains | 7 months ago |
Tectonic Therapeutic IncTECX | 3 | Strong Buy | $60.00 | +93.67% | Maintains | 7 months ago |
Palvella Therapeutics IncPVLA | 4 | Strong Buy | $190.00 | +20.43% | Maintains | 8 months ago |
Upstream Bio IncUPB | 1 | Strong Buy | $47.00 | +548.28% | Initiates Coverage On | 10 months ago |
Jefferson Capital IncJCAP | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | a year ago |
Uniqure NvQURE | 6 | Strong Buy | $52.00 | N/A | Upgrades | 2 years ago |
Biomarin Pharmaceutical IncBMRN | 1 | Buy | $79.00 | N/A | Reinstates | 2 years ago |
Regenxbio IncRGNX | 1 | Buy | $18.00 | N/A | Reinstates | 2 years ago |
Sarepta Therapeutics IncSRPT | 2 | Buy | $150.00 | N/A | Reinstates | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Buy | $50.00 | N/A | Reinstates | 2 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Buy | $51.00 | N/A | Reinstates | 2 years ago |
Passage Bio IncPASG | 5 | Buy | $100.00 | N/A | Maintains | 3 years ago |
Ptc Therapeutics IncPTCT | 6 | Buy | $55.00 | N/A | Maintains | 3 years ago |
Kyntra Bio IncKYNB | 2 | Buy | $875.00 | N/A | Upgrades | 4 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Acadia Pharmaceuticals IncACAD | 2 | Buy | $35.00 | N/A | Downgrades | 5 years ago |
Global Blood Therapeutics IncGBT | 4 | Hold | $50.00 | N/A | Downgrades | 6 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Zogenix IncZGNX | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Buy | $28.00 | N/A | Assumes | 8 years ago |
Sage Therapeutics IncSAGE | 1 | Buy | $82.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.